|
|
||||||||
Infectious agents must acquire iron from their host to survive, and iron deficiency has been reported to protect against malaria in humans. We have tested the the susceptibility of Plasmodium falciparum to iron deprivation by studying the effect of desferrioxamine (DF), a specific iron chelating agent, on parasite growth in an in vitro culture system. We have found that DF inhibits the growth of P. falciparum at concentrations readily achievable in vivo, by a mechanism that may involve interference with the completion of schizogony.
Accepted for publication January 13, 1982.
This article has been cited by other articles:
![]() |
M. Miethke and M. A. Marahiel Siderophore-Based Iron Acquisition and Pathogen Control Microbiol. Mol. Biol. Rev., September 1, 2007; 71(3): 413 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna, T. Fusai, J. Mosnier, W. Daries, J. F. Trape, G. Kunesch, et al. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum J. Antimicrob. Chemother., June 1, 2006; 57(6): 1093 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pradines, J. M. Rolain, F. Ramiandrasoa, T. Fusai, J. Mosnier, C. Rogier, W. Daries, E. Baret, G. Kunesch, J. Le Bras, et al. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum J. Antimicrob. Chemother., August 1, 2002; 50(2): 177 - 187. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |